Literature DB >> 32345141

Heparin conjugated PCL/Gel - PCL/Gel/n-HA bilayer fibrous membrane for potential regeneration of soft and hard tissues.

Jie Liu1, Qin Zou1, Bin Cai1, Jiawei Wei1, Chen Yuan1, Yubao Li1.   

Abstract

A novel bilayer fibrous membrane for guided tissue regeneration (GTR) was prepared via two-step electrospinning process, subsequent crosslinking and surface conjugation with heparin. The bilayer membrane consists of upper layer polycaprolactone/gelatin (PCL/Gel) membrane for soft tissue regeneration and lower layer PCL/Gel/nano-hydroxyapatite (PCL/Gel/n-HA) membrane for hard tissue regeneration. The results indicated that the physicochemical and biological properties of the membrane were strongly influenced by the crosslinking time and by the heparin conjugation. Crosslinking effectively prolonged the degradation time while maintaining the membrane barrier function, and the surface heparin conjugation obviously improved the biological performance of the membrane. An enhanced cell adhesion and proliferation were observed on the heparin-conjugated fibrous membranes, which also showed good histocompatibility and favorable in vivo degradability. The electrospun bilayer fibrous membrane may have promising prospect for modulation of cell response and simultaneous regeneration of soft and hard tissues.

Entities:  

Keywords:  Electrospun fibers; bilayer membrane; heparin conjugation; tissue regeneration

Year:  2020        PMID: 32345141     DOI: 10.1080/09205063.2020.1760700

Source DB:  PubMed          Journal:  J Biomater Sci Polym Ed        ISSN: 0920-5063            Impact factor:   3.517


  2 in total

Review 1.  Layered scaffolds in periodontal regeneration.

Authors:  Niloufar Abedi; Negar Rajabi; Mahshid Kharaziha; Farahnaz Nejatidanesh; Lobat Tayebi
Journal:  J Oral Biol Craniofac Res       Date:  2022-09-13

Review 2.  Engineering Myocardium for Heart Regeneration-Advancements, Considerations, and Future Directions.

Authors:  Dillon K Jarrell; Ethan J Vanderslice; Mitchell C VeDepo; Jeffrey G Jacot
Journal:  Front Cardiovasc Med       Date:  2020-10-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.